News

August 16, 2021

Meet BioSkryb’s New Commercial Team Members Providing Customer Care and Technical Support

Meet BioSkryb’s New Commercial Team Members We are excited to welcome three new team members who bring deep scientific knowledge as well as technical experience in supporting researcher needs in applying new genomic and molecular biology solutions. “Just as we know each cell is unique, so are our people,”...

August 4, 2021

In-depth empowerment and innovation! 2021 MGI & IDG Capital Life and Health Acceleration Camp officially opens

July 31 – Huatai Zhi made (MGI), IDG investment Innovation Institute and Blue Rainbow Life Sciences Accelerator jointly organized by the MGI & IDG capital accelerated life and health business (hereinafter referred to as “accelerated Camp”) in the Nanshan District, Shenzhen, IDG Capital Innovation the Investment Research Institute officially...

June 30, 2021

BioSkryb Appoints Gary Harton, Ph.D., Chief Scientific Officer

BioSkryb Appoints Gary Harton, Ph.D., Chief Scientific Officer DURHAM, N.C., June 30, 2021 — BioSkryb, Inc., today announced the expansion of the company’s leadership team with the appointment of Gary Harton, Ph.D., as Chief Scientific Officer. He has more than 30 years of experience in single cell diagnostic product...

April 22, 2021

BioSkryb Appoints Sean Keohane Senior Vice President of Commercial Operations

DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., today announced the expansion of the company’s leadership team with the appointment of Sean Keohane as Senior Vice President of Commercial Operations. Keohane has more than 25 years of experience in life science product commercialization, with demonstrated success in building strong teams and implementing strategic...

March 10, 2021

Top 10 BioTech Industry Trends & Innovations in 2021

The BioTech industry is adopting trends like artificial intelligence (AI), data analytics, and automation to optimize production. Consequently, there has been a rise in consumer BioTech or BioTech products targeted directly at customers instead of biopharma or healthcare businesses. While the industry largely still focuses on medicine, startups are...

March 2, 2021

BioSkryb Announces the Winners of Its Grant Program to Aid Research Using Primary Template-directed Amplification Technology

DURHAM, N.C.–(BUSINESS WIRE)–Today, at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting held virtually, BioSkryb, Inc., a developer of genomic amplification technologies, announced the winners of a research grant program sponsored by the company. The grant program was created to accelerate innovation of single-cell genomic studies using...

December 10, 2020

BioSkryb Announces Research Grants to Access Breakthrough Single-Cell Whole Genome Amplification Technologies

DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today announced the launch of a research grant program sponsored by the company to accelerate innovation of single-cell genomic studies using its primary template-directed amplification (PTA) technology, now commercially available as the ResolveDNA™ suite of products. The program will...

December 1, 2020

BioSkryb Announces First Data Demonstrating Novel PTA Technology Improves Accuracy in Whole Genome Amplification for Single Cell Analyses

December 01, 2020 08:00 AM EST DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today reported the release of foundational data before publication on the preprint server, bioRxiv, demonstrating the superior ability of primary template-directed amplification (PTA) to accurately and uniformly amplify the genomes of single cells....

October 27, 2020

BioSkryb’s Novel PTA Technology for High-Quality Single-Cell Whole Genome Amplification Will Be Commercially Available for the First Time at ASHG 2020

Research being presented at ASHG 2020 to support use of PTA technology in the study of genetic variants that contribute to drug resistance in cancer treatment October 26, 2020 09:00 AM Eastern Daylight Time DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb, Inc., a developer of genomic amplification technologies, today announced the commercial launch...

August 3, 2020

BioSkryb Launches Researcher Early Access Program for Genomic Amplification Technology

DURHAM, NC, Aug. 3, 2020 — BioSkryb, Inc. (“BioSkryb”), a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced that it has launched an Early Access Program (EAP) for researchers to test its proprietary genomic amplification technology (Primary Template-directed Amplification or PTA)....